2m 2m 2m 2m 2m 2m 2m
NEPHROS (NEPH)
NASDAQ
$3.04-$0.27 (-8.16%)
Price as of Nov 13, 2026 1:26 PM EST- $36.0MMarket Cap
- -25.11%1-Year Change
- Medical Instruments & SuppliesIndustry
NEPHROS (NEPH)
$3.04-$0.27 (-8.16%)
NEPH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.31 | ||
Change | +$0.24 (+7.82%) | ||
Open | $3.27 | ||
High | $3.43 | ||
Low | $3.09 | ||
Previous Close | $3.07 | ||
Volume | 111,933 | ||
30-Day Average Volume | 60,839 | ||
1-Week Change | 7.12% | ||
1-Month Change | -7.28% | ||
1-Year Change | -25.11% | ||
3-Year Change | 68.88% | ||
5-Year Change | -55.27% | ||
Fundamentals | |||
Shares Outstanding | 10.9M | ||
Total Assets | $15.3M | ||
Market Cap | $36.0M | ||
Enterprise Value | $31.4M | ||
Period: QTR TTM FY | |||
Revenue | $5.4M | ||
Net Income | $512,000.00 | ||
Free Cash Flow | -$150,000.00 | ||
EBIT | $512,000.00 | ||
EBITDA | $523,000.00 | ||
Net Working Capital | $10.8M | ||
EPS | $0.05 | ||
Enterprise Value/EBITDA | 60 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 3 | ||
P/E | 66 | ||
PEG | -1 | ||
Price/Free Cash Flow | -240 | ||
Price/Operating Cash Flow | -240 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 9 | ||
Last Split Date | 07/10/2019 | ||
Earnings & Revenue